Biomarkers of Ovarian Reserve—Do They Predict Somatic Aging?

Marcelle I. Cedars

doi:10.1055/s-0033-1356480

Seminars in Reproductive Medicine, Inhaltsverzeichnis

Semin Reprod Med 2013; 31(06): 443-451
DOI: 10.1055/s-0033-1356480

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Biomarkers of Ovarian Reserve—Do They Predict Somatic Aging?

Marcelle I. Cedars

¹Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, UCSF Women's Health Clinical Research Center, San Francisco, California

› Institutsangaben

Abstract

Menopause, while the end of reproduction, also represents a major hormonal, psychological and physiological event in the lives of all women. Several studies have suggested an association between the age of menopause and longevity. Additionally, cellular and molecular mechanisms of general aging have been suggested to play a vital role in ovarian aging. In parallel with the recognition of these similar physiological parameters, markers of “ovarian age,” also known as ovarian reserve, have been developed. These markers may allow prediction of age of menopause and the identification of women at increased risk for earlier menopause, and perhaps advanced somatic aging. The ability to identify these women would be critically important if decreased ovarian reserve were associated with increased long-term health risks. Thus, it is critical to understand if ovarian aging, and particularly, early ovarian aging, would place women at risk for long-term health issues with increased morbidity and mortality. Numerous studies reviewed support an association between menopause, and premenopausal changes consistent with diminish ovarian reserve, and cardiovascular risk, bone loss and changes in mood and cognition. Only longitudinal studies will be able to confirm if any identified associations reflect causality or common underlying risk, but the available data suggest women with diminished ovarian reserve represent a unique group that may be at increased risk for long-term health effects beyond fertility loss.

Keywords

ovarian aging - somatic aging - oxidative stress - mitochondrial function and aging

Volltext

Referenzen

References
1 van Rooij IA, Tonkelaar Id, Broekmans FJ , et al. Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 2004; 11 (6, Pt 1) 601-606
2 Broekmans FJ, Faddy MJ, Scheffer G, te Velde ER. Antral follicle counts are related to age at natural fertility loss and age at menopause. Menopause 2004; 11 (6, Pt 1) 607-614
3 Broer SL, Eijkemans MJ, Scheffer GJ , et al. Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab 2011; 96 (8) 2532-2539
4 Tehrani FR, Solaymani-Dodaran M, Tohidi M, Gohari MR, Azizi F. Modeling age at menopause using serum concentration of anti-mullerian hormone. J Clin Endocrinol Metab 2013; 98 (2) 729-735
5 Freeman EW, Sammel MD, Lin H, Gracia CR. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab 2012; 97 (5) 1673-1680
6 Wellons MF, Bates GW, Schreiner PJ, Siscovick DS, Sternfeld B, Lewis CE. Antral follicle count predicts natural menopause in a population-based sample: the Coronary Artery Risk Development in Young Adults Women's Study. Menopause 2013; 20 (8) 825-830
7 Snowdon DA, Kane RL, Beeson WL , et al. Is early natural menopause a biologic marker of health and aging?. Am J Public Health 1989; 79 (6) 709-714
8 Cooper GS, Sandler DP. Age at natural menopause and mortality. Ann Epidemiol 1998; 8 (4) 229-235
9 Cooper GS, Baird DD, Weinberg CR, Ephross SA, Sandler DP. Age at menopause and childbearing patterns in relation to mortality. Am J Epidemiol 2000; 151 (6) 620-623
10 Jansen SC, Temme EH, Schouten EG. Lifetime estrogen exposure versus age at menopause as mortality predictor. Maturitas 2002; 43 (2) 105-112
11 Jacobsen BK, Heuch I, Kvåle G. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol 2003; 157 (10) 923-929
12 Mondul AM, Rodriguez C, Jacobs EJ, Calle EE. Age at natural menopause and cause-specific mortality. Am J Epidemiol 2005; 162 (11) 1089-1097
13 Ossewaarde ME, Bots ML, Verbeek AL , et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology 2005; 16 (4) 556-562
14 Tom SE, Cooper R, Wallace RB, Guralnik JM. Type and timing of menopause and later life mortality among women in the Iowa Established Populations for the Epidemiological Study of the Elderly (EPESE) cohort. J Womens Health (Larchmt) 2012; 21 (1) 10-16
15 Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11 (3) 298-300
16 Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11 (3) 298-300
17 Miquel J, Economos AC, Fleming J, Johnson Jr JE. Mitochondrial role in cell aging. Exp Gerontol 1980; 15 (6) 575-591
18 Kotrschal A, Ilmonen P, Penn DJ. Stress impacts telomere dynamics. Biol Lett 2007; 3 (2) 128-130
19 Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408 (6809) 239-247
20 von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27 (7) 339-344
21 Haendeler J, Hoffmann J, Brandes RP, Zeiher AM, Dimmeler S. Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol Cell Biol 2003; 23 (13) 4598-4610
22 Malinger G, Zakut H, Soreq H. Cholinoceptive properties of human primordial, preantral, and antral oocytes: in situ hybridization and biochemical evidence for expression of cholinesterase genes. J Mol Neurosci 1989; 1 (2) 77-84
23 Singh B, Rutledge JM, Armstrong DT. Epidermal growth factor and its receptor gene expression and peptide localization in porcine ovarian follicles. Mol Reprod Dev 1995; 40 (4) 391-399
24 Keefe D. MtDNA deletions on oocytes and reproductive aging in women. Fertil Steril 1995; 64 (3) 577-583
25 Brenner CA, Wolny YM, Barritt JA, Matt DW, Munné S, Cohen J. Mitochondrial DNA deletion in human oocytes and embryos. Mol Hum Reprod 1998; 4 (9) 887-892
26 Tarín JJ. Aetiology of age-associated aneuploidy: a mechanism based on the 'free radical theory of ageing'. Hum Reprod 1995; 10 (6) 1563-1565
27 Phaneuf S, Leeuwenburgh C. Cytochrome c release from mitochondria in the aging heart: a possible mechanism for apoptosis with age. Am J Physiol Regul Integr Comp Physiol 2002; 282 (2) R423-R430
28 Lodish H, Berk A, Zipursky LS , et al. Cellular energetics: glycolysis, aerobic oxidation, and photosynthesis. In: Freeman WH, , ed. Molecular Cell Biology. 2000: http://www.ncbi.nlm.nih.gov/books/bv.fcgi?highlight=mitochondrial,function&rid=mcb.section.4377#4383
29 May-Panloup P, Chretien MF, Malthiery Y, Reynier P. Mitochondrial DNA in the oocyte and the developing embryo. Curr Top Dev Biol 2007; 77: 51-83
30 Barritt JA, Kokot M, Cohen J, Steuerwald N, Brenner CA. Quantification of human ooplasmic mitochondria. Reprod Biomed Online 2002; 4 (3) 243-247
31 Leese HJ, Barton AM. Pyruvate and glucose uptake by mouse ova and preimplantation embryos. J Reprod Fertil 1984; 72 (1) 9-13
32 Fujino Y, Ozaki K, Yamamasu S , et al. DNA fragmentation of oocytes in aged mice. Hum Reprod 1996; 11 (7) 1480-1483
33 Perez GI, Jurisicova A, Matikainen T , et al. A central role for ceramide in the age-related acceleration of apoptosis in the female germline. FASEB J 2005; 19 (7) 860-862
34 Eichenlaub-Ritter U, Vogt E, Yin H, Gosden R. Spindles, mitochondria and redox potential in ageing oocytes. Reprod Biomed Online 2004; 8 (1) 45-58
35 Blackburn EH. Telomere states and cell fates. Nature 2000; 408 (6808) 53-56
36 Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 2006; 12 (10) 1133-1138
37 Sitte N, Saretzki G, von Zglinicki T. Accelerated telomere shortening in fibroblasts after extended periods of confluency. Free Radic Biol Med 1998; 24 (6) 885-893
38 Kawanishi S, Oikawa S. Mechanism of telomere shortening by oxidative stress. Ann N Y Acad Sci 2004; 1019: 278-284
39 Zhang P, Dilley C, Mattson MP. DNA damage responses in neural cells: Focus on the telomere. Neuroscience 2007; 145 (4) 1439-1448
40 Hezel AF, Bardeesy N, Maser RS. Telomere induced senescence: end game signaling. Curr Mol Med 2005; 5 (2) 145-152
41 Aviv A. Telomeres and human aging: facts and fibs. Sci SAGE KE 2004; 2004 (51) pe43
42 Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003; 361 (9355) 393-395
43 Martin-Ruiz C, Dickinson HO, Keys B, Rowan E, Kenny RA, Von Zglinicki T. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol 2006; 60 (2) 174-180
44 Beyne-Rauzy O, Prade-Houdellier N, Demur C , et al. Tumor necrosis factor-alpha inhibits hTERT gene expression in human myeloid normal and leukemic cells. Blood 2005; 106 (9) 3200-3205
45 Fu W, Lu C, Mattson MP. Telomerase mediates the cell survival-promoting actions of brain-derived neurotrophic factor and secreted amyloid precursor protein in developing hippocampal neurons. J Neurosci 2002; 22 (24) 10710-10719
46 Gorbunova V, Seluanov A, Pereira-Smith OM. Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis. J Biol Chem 2002; 277 (41) 38540-38549
47 Mattson MP, Fu W, Zhang P. Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective. Mech Ageing Dev 2001; 122 (7) 659-671
48 Liu L, Trimarchi JR, Smith PJ, Keefe DL. Mitochondrial dysfunction leads to telomere attrition and genomic instability. Aging Cell 2002; 1 (1) 40-46
49 Liu L, Franco S, Spyropoulos B, Moens PB, Blasco MA, Keefe DL. Irregular telomeres impair meiotic synapsis and recombination in mice. Proc Natl Acad Sci U S A 2004; 101 (17) 6496-6501
50 Liu L, Trimarchi JR, Navarro P, Blasco MA, Keefe DL. Oxidative stress contributes to arsenic-induced telomere attrition, chromosome instability, and apoptosis. J Biol Chem 2003; 278 (34) 31998-32004
51 Keefe DL, Franco S, Liu L , et al. Telomere length predicts embryo fragmentation after in vitro fertilization in women—toward a telomere theory of reproductive aging in women. Am J Obstet Gynecol 2005; 192 (4) 1256-1260 , discussion 1260–1261
52 Butts SF, Seifer DB. Racial and ethnic differences in reproductive potential across the life cycle. Fertil Steril 2010; 93 (3) 681-690
53 Sohal RS, Orr WC. The redox stress hypothesis of aging. Free Radic Biol Med 2012; 52 (3) 539-555
54 Soules MR, Sherman S, Parrott E , et al. Stages of Reproductive Aging Workshop (STRAW). J Womens Health Gend Based Med 2001; 10 (9) 843-848
55 Lambalk CB, van Disseldorp J, de Koning CH, Broekmans FJ. Testing ovarian reserve to predict age at menopause. Maturitas 2009; 63 (4) 280-291
56 Lawson R, El-Toukhy T, Kassab A , et al. Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. Hum Reprod 2003; 18 (3) 527-533
57 de Boer EJ, den Tonkelaar I, te Velde ER, Burger CW, Klip H, van Leeuwen FE ; OMEGA-project group. A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril 2002; 77 (5) 978-985
58 van Disseldorp J, Faddy MJ, Themmen AP , et al. Relationship of serum antimüllerian hormone concentration to age at menopause. J Clin Endocrinol Metab 2008; 93 (6) 2129-2134
59 Lisabeth LD, Beiser AS, Brown DL, Murabito JM, Kelly-Hayes M, Wolf PA. Age at natural menopause and risk of ischemic stroke: the Framingham heart study. Stroke 2009; 40 (4) 1044-1049
60 Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas 2010; 65 (2) 161-166
61 Feng Y, Hong XM, Wilker E , et al. Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases. Atherosclerosis 2008; 196 (2) 590-597
62 Parashar S, Reid KJ, Spertus JA, Shaw LJ, Vaccarino V. Early menopause predicts angina after myocardial infarction. Menopause 2010; 17 (5) 938-945
63 Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 316 (18) 1105-1110
64 Park HT, Cho GJ, Ahn KH , et al. Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 2010; 72 (1) 26-31
65 Jacobsen BK, Nilssen S, Heuch I, Kvåle G. Does age at natural menopause affect mortality from ischemic heart disease?. J Clin Epidemiol 1997; 50 (4) 475-479
66 van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet 1996; 347 (9003) 714-718
67 Roy SK, Terada DM. Activities of glucose metabolic enzymes in human preantral follicles: in vitro modulation by follicle-stimulating hormone, luteinizing hormone, epidermal growth factor, insulin-like growth factor I, and transforming growth factor beta1. Biol Reprod 1999; 60 (3) 763-768
68 Palmer JR, Rosenberg L, Shapiro S. Reproductive factors and risk of myocardial infarction. Am J Epidemiol 1992; 136 (4) 408-416
69 Fioretti F, Tavani A, Gallus S, Franceschi S, La Vecchia C. Menopause and risk of non-fatal acute myocardial infarction: an Italian case-control study and a review of the literature. Hum Reprod 2000; 15 (3) 599-603
70 Lin JW, Caffrey JL, Chang MH, Lin YS. Sex, menopause, metabolic syndrome, and all-cause and cause-specific mortality—cohort analysis from the Third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 2010; 95 (9) 4258-4267
71 de Kleijn MJ, van der Schouw YT, van der Graaf Y. Reproductive history and cardiovascular disease risk in postmenopausal women: a review of the literature. Maturitas 1999; 33 (1) 7-36
72 Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006; 13 (2) 265-279
73 Cui R, Iso H, Toyoshima H , et al; JACC Study Group. Relationships of age at menarche and menopause, and reproductive year with mortality from cardiovascular disease in Japanese postmenopausal women: the JACC study. J Epidemiol 2006; 16 (5) 177-184
74 Joakimsen O, Bønaa KH, Stensland-Bugge E, Jacobsen BK. Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis: The Tromsø Study. J Clin Epidemiol 2000; 53 (5) 525-530
75 Jacobsen BK, Knutsen SF, Fraser GE. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J Clin Epidemiol 1999; 52 (4) 303-307
76 Matthews KA, Santoro N, Lasley B , et al. Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases. J Clin Endocrinol Metab 2006; 91 (5) 1789-1795
77 Gorgels WJ, , v d Graaf Y, Blankenstein MA, Collette HJ, Erkelens DW, Banga JD. Urinary sex hormone excretions in premenopausal women and coronary heart disease risk: a nested case-referent study in the DOM-cohort. J Clin Epidemiol 1997; 50 (3) 275-281
78 Solomon CG, Hu FB, Dunaif A , et al. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 2002; 87 (5) 2013-2017
79 Punnonen R, Jokela H, Aine R, Teisala K, Salomäki A, Uppa H. Impaired ovarian function and risk factors for atherosclerosis in premenopausal women. Maturitas 1997; 27 (3) 231-238
80 Bairey Merz CN, Johnson BD, Sharaf BL , et al; WISE Study Group. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol 2003; 41 (3) 413-419
81 Gast GC, Grobbee DE, Smit HA, Bueno-de-Mesquita HB, Samsioe GN, van der Schouw YT. Menstrual cycle characteristics and risk of coronary heart disease and type 2 diabetes. Fertil Steril 2010; 94 (6) 2379-2381
82 Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009; 360 (6) 606-614
83 De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010; 376 (9744) 911-921
84 Kalantaridou SN, Naka KK, Papanikolaou E , et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab 2004; 89 (8) 3907-3913
85 Clarkson TB. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause 2007; 14 (3, Pt 1) 373-384
86 Sanders JL, Newman AB. Telomere Length in Epidemiology: A Biomarker of Aging, Age-Related Disease, Both, or Neither?. Epidemiol Rev 2013; (Jan) 9
87 Sobenin IA, Chistiakov DA, Bobryshev YV, Postnov AY, Orekhov AN. Mitochondrial Mutations in Atherosclerosis: New Solutions in Research and Possible Clinical Applications. Curr Pharm Des 2013; (Feb) 15
88 Li X, Fang P, Mai J, Choi ET, Wang H, Yang XF. Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J Hematol Oncol 2013; 6: 19
89 Fyhrquist F, Saijonmaa O. Telomere length and cardiovascular aging. Ann Med 2012; 44 (Suppl. 01) S138-S142
90 Huzen J, de Boer RA, van Veldhuisen DJ, van Gilst WH, van der Harst P. The emerging role of telomere biology in cardiovascular disease. Front Biosci (Landmark Ed) 2010; 15: 35-45
91 De Meyer T, Rietzschel ER, De Buyzere ML, Van Criekinge W, Bekaert S. Telomere length and cardiovascular aging: the means to the ends?. Ageing Res Rev 2011; 10 (2) 297-303
92 Pal L, Zhang K, Zeitlian G, Santoro N. Characterizing the reproductive hormone milieu in infertile women with diminished ovarian reserve. Fertil Steril 2010; 93 (4) 1074-1079
93 Mersereau JE, Evans ML, Moore DH , et al. Luteal phase estrogen is decreased in regularly menstruating older women compared with a reference population of younger women. Menopause 2008; 15 (3) 482-486
94 Matthews KA, Crawford SL, Chae CU , et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?. J Am Coll Cardiol 2009; 54 (25) 2366-2373
95 Matthews KA, Kuller LH, Chang Y, Edmundowicz D. Premenopausal risk factors for coronary and aortic calcification: a 20-year follow-up in the healthy women study. Prev Med 2007; 45 (4) 302-308
96 Kuller LH, Matthews KA, Sutton-Tyrrell K, Edmundowicz D, Bunker CH. Coronary and aortic calcification among women 8 years after menopause and their premenopausal risk factors: the healthy women study. Arterioscler Thromb Vasc Biol 1999; 19 (9) 2189-2198
97 Lee JS, Hayashi K, Mishra G, Yasui T, Kubota T, Mizunuma H. Independent association between age at natural menopause and hypercholesterolemia, hypertension, and diabetes mellitus: Japan nurses' health study. J Atheroscler Thromb 2013; 20 (2) 161-169
98 Wellons M, Ouyang P, Schreiner PJ, Herrington DM, Vaidya D. Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis. Menopause 2012; 19 (10) 1081-1087
99 Jacobsen BK, Knutsen SF, Fraser GE. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J Clin Epidemiol 1999; 52 (4) 303-307
100 Hu FB, Grodstein F, Hennekens CH , et al. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 1999; 159 (10) 1061-1066
101 Løkkegaard E, Jovanovic Z, Heitmann BL, Keiding N, Ottesen B, Pedersen AT. The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy. Maturitas 2006; 53 (2) 226-233
102 Baba Y, Ishikawa S, Amagi Y, Kayaba K, Gotoh T, Kajii E. Premature menopause is associated with increased risk of cerebral infarction in Japanese women. Menopause 2010; 17 (3) 506-510
103 Cramer DW, Xu H, Harlow BL. Family history as a predictor of early menopause. Fertil Steril 1995; 64 (4) 740-745
104 Torgerson DJ, Thomas RE, Reid DM. Mothers and daughters menopausal ages: is there a link?. Eur J Obstet Gynecol Reprod Biol 1997; 74 (1) 63-66
105 van Asselt KM, Kok HS, Pearson PL , et al. Heritability of menopausal age in mothers and daughters. Fertil Steril 2004; 82 (5) 1348-1351
106 Mishra G, Hardy R, Kuh D. Are the effects of risk factors for timing of menopause modified by age? Results from a British birth cohort study. Menopause 2007; 14 (4) 717-724
107 Kok HS, van Asselt KM, van der Schouw YT , et al. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol 2006; 47 (10) 1976-1983
108 Lloyd-Jones DM, Leip EP, Larson MG , et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006; 113 (6) 791-798
109 Berry JD, Liu K, Folsom AR , et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Circulation 2009; 119 (3) 382-389
110 Berry JD, Dyer A, Cai X , et al. Lifetime risks of cardiovascular disease. N Engl J Med 2012; 366 (4) 321-329
111 Chu MC, Rath KM, Huie J, Taylor HS. Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk. Hum Reprod 2003; 18 (8) 1570-1573
112 Pal L, Bevilacqua K, Zeitlian G, Shu J, Santoro N. Implications of diminished ovarian reserve (DOR) extend well beyond reproductive concerns. Menopause 2008; 15 (6) 1086-1094
113 Pal L, Norian J, Zeitlian G, Bevilacqua K, Freeman R, Santoro N. Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density. Fertil Steril 2008; 90 (5) 1626-1634
114 Wu Z, Boss O. Targeting PGC-1 alpha to control energy homeostasis. Expert Opin Ther Targets 2007; 11 (10) 1329-1338
115 Sun L, Zhang Z, Zhu LL , et al. Further evidence for direct pro-resorptive actions of FSH. Biochem Biophys Res Commun 2010; 394 (1) 6-11
116 Robinson LJ, Tourkova I, Wang Y , et al. FSH-receptor isoforms and FSH-dependent gene transcription in human monocytes and osteoclasts. Biochem Biophys Res Commun 2010; 394 (1) 12-17
117 Zhu LL, Blair H, Cao J , et al. Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis. Proc Natl Acad Sci U S A 2012; 109 (36) 14574-14579
118 Geng W, Yan X, Du H, Cui J, Li L, Chen F. Immunization with FSHβ fusion protein antigen prevents bone loss in a rat ovariectomy-induced osteoporosis model. Biochem Biophys Res Commun 2013; 434 (2) 280-286
119 Soares CN, Maki PM. Menopausal transition, mood, and cognition: an integrated view to close the gaps. Menopause 2010; 17 (4) 812-814
120 Boulware MI, Kent BA, Frick KM. The impact of age-related ovarian hormone loss on cognitive and neural function. Curr Top Behav Neurosci 2012; 10: 165-184
121 Maki PM, Freeman EW, Greendale GA , et al. Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition. Menopause 2010; 17 (4) 815-822
122 Barron AM, Pike CJ. Sex hormones, aging, and Alzheimer's disease. Front Biosci (Elite Ed) 2012; 4: 976-997
123 Henderson VW, Brinton RD. Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. Prog Brain Res 2010; 182: 77-96
124 Grimm A, Lim YA, Mensah-Nyagan AG, Götz J, Eckert A. Alzheimer's disease, oestrogen and mitochondria: an ambiguous relationship. Mol Neurobiol 2012; 46 (1) 151-160
125 Yao J, Brinton RD. Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease. Adv Pharmacol 2012; 64: 327-371
126 Long J, He P, Shen Y, Li R. New evidence of mitochondria dysfunction in the female Alzheimer's disease brain: deficiency of estrogen receptor-β. J Alzheimers Dis 2012; 30 (3) 545-558
127 Schupf N, Pang D, Patel BN , et al. Onset of dementia is associated with age at menopause in women with Down's syndrome. Ann Neurol 2003; 54 (4) 433-438
128 Coppus AM, Evenhuis HM, Verberne GJ , et al. Early age at menopause is associated with increased risk of dementia and mortality in women with Down syndrome. J Alzheimers Dis 2010; 19 (2) 545-550
129 Geerlings MI, Ruitenberg A, Witteman JC , et al. Reproductive period and risk of dementia in postmenopausal women. JAMA 2001; 285 (11) 1475-1481
130 Rocca WA, Grossardt BR, Shuster LT. Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res 2011; 1379: 188-198
131 Amtul Z, Wang L, Westaway D, Rozmahel RF. Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease. Neuroscience 2010; 169 (2) 781-786
132 Zhao L, Yao J, Mao Z, Chen S, Wang Y, Brinton RD. 17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention. Neurobiol Aging 2011; 32 (11) 1949-1963
133 Whitmer RA, Quesenberry CP, Zhou J, Yaffe K. Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol 2011; 69 (1) 163-169
134 Sherwin BB. Estrogen and cognitive functioning in women: lessons we have learned. Behav Neurosci 2012; 126 (1) 123-127
135 Salpeter SR, Buckley NS, Liu H, Salpeter EE. The cost-effectiveness of hormone therapy in younger and older postmenopausal women. Am J Med 2009; 122 (1) 42-52 , e2
136 Shumaker SA, Legault C, Kuller L , et al; Women's Health Initiative Memory Study. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291 (24) 2947-2958
137 Coker LH, Espeland MA, Rapp SR , et al. Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS). J Steroid Biochem Mol Biol 2010; 118 (4-5) 304-310
138 Berent-Spillson A, Persad CC, Love T , et al. Hormonal environment affects cognition independent of age during the menopause transition. J Clin Endocrinol Metab 2012; 97 (9) E1686-E1694
139 Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 2006; 63 (4) 385-390
140 Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006; 63 (4) 375-382
141 Greendale GA, Huang MH, Wight RG , et al. Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology 2009; 72 (21) 1850-1857
142 Schmidt PJ, Nieman L, Danaceau MA , et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 2000; 183 (2) 414-420
143 Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001; 58 (6) 529-534
144 Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 2004; 55 (4) 406-412
145 Weber M, Mapstone M. Memory complaints and memory performance in the menopausal transition. Menopause 2009; 16 (4) 694-700
146 McEwen BS. Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol 2001; 91 (6) 2785-2801
147 Deecher D, Andree TH, Sloan D, Schechter LE. From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology 2008; 33 (1) 3-17
148 Eriksson O, Landén M, Sundblad C, Holte J, Eriksson E, Naessén T. Ovarian morphology in premenstrual dysphoria. Psychoneuroendocrinology 2012; 37 (6) 742-751
149 Becker D, Orr A, Weizman A, Kotler M, Pines A. Depressed mood through women's reproductive cycle: correlation to mood at menopause. Climacteric 2007; 10 (1) 46-50
150 Bhagat M, Mukherjee S, De P , et al. Clustering of cardiometabolic risk factors in Asian Indian women: Santiniketan women study. Menopause 2010; 17 (2) 359-364
151 Bleil ME, Adler NE, Pasch LA , et al. Depressive symptomatology, psychological stress, and ovarian reserve: a role for psychological factors in ovarian aging?. Menopause 2012; 19 (11) 1176-1185
152 Bleil ME, Adler NE, Pasch LA , et al. Psychological stress and reproductive aging among pre-menopausal women. Hum Reprod 2012; 27 (9) 2720-2728